Celldex Therapeutics reported $-23257000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Aptinyx Inc APTX:US $ -19379000 207K
Celldex Therapeutics CLDX:US $ -23.26M 2.92M
Cytrx CYTR:US -1294610 7.73M
Immunogen IMGN:US $ -22.85M 11.7M
Nektar Therapeutics NKTR:US $ -112.91M 0.69M
Newlink Genetics NLNK:US -7731000 1.16M
Northwest Biotherapeutics NWBO:US -10697000 648K